Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B, a viral infection affecting the liver. It contains hepatitis B surface antigen (rDNA) and alum as an adjuvant. This vaccine is suitable for individuals at risk of hepatitis B infection.

Engerix-B is primarily used for the prevention of hepatitis B, a serious liver infection caused by the hepatitis B virus. It is often recommended for individuals who are at higher risk of exposure, such as healthcare workers, travelers to regions with high rates of hepatitis B, and those with certain medical conditions. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus, providing protection against future infections.

Common effects of Engerix-B may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue. These effects are typically mild and short-lived. Severe allergic reactions are rare but can occur and may require immediate medical attention.

Engerix-B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or medications. Pregnant or breastfeeding women should consult their healthcare provider before receiving the vaccine.

Engerix-B may interact with certain medications or other vaccines. It is important to inform the healthcare provider about all current medications and recent vaccinations. Alcohol and other substances that weaken the immune system may affect the vaccine's effectiveness. Always consult a healthcare professional for personalized advice.